![Timothy Keutzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Keutzer
Direttore operativo presso
SPERO THERAPEUTICS, INC.
Patrimonio netto: 405 512 $ in data 30/09/2026
Profilo
Timothy Keutzer is currently Chief Operating Officer at Spero Therapeutics, Inc. since 2023.
Formerly, Mr. Keutzer was Vice President-Program & Portfolio Management at Cubist Pharmaceuticals LLC from 2014 to 2015.
Mr. Keutzer completed undergraduate education at the University of Kentucky.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 335.134 ( 0,58% ) | 405 512 $ | 30/09/2026 |
Posizioni attive di Timothy Keutzer
| Società | Posizione | Inizio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Direttore operativo | 01/02/2023 |
Precedenti posizioni note di Timothy Keutzer
| Società | Posizione | Fine |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2015 |
Formazione di Timothy Keutzer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
49
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
